PMC:7546716 / 24696-25291 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T469","span":{"begin":97,"end":102},"obj":"Body_part"},{"id":"T470","span":{"begin":111,"end":116},"obj":"Body_part"},{"id":"T471","span":{"begin":493,"end":499},"obj":"Body_part"},{"id":"T472","span":{"begin":544,"end":550},"obj":"Body_part"},{"id":"T473","span":{"begin":554,"end":556},"obj":"Body_part"},{"id":"T474","span":{"begin":587,"end":594},"obj":"Body_part"}],"attributes":[{"id":"A469","pred":"fma_id","subj":"T469","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A470","pred":"fma_id","subj":"T470","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A471","pred":"fma_id","subj":"T471","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A472","pred":"fma_id","subj":"T472","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A473","pred":"fma_id","subj":"T473","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A474","pred":"fma_id","subj":"T474","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":84,"end":93},"obj":"Body_part"},{"id":"T26","span":{"begin":97,"end":102},"obj":"Body_part"},{"id":"T27","span":{"begin":111,"end":116},"obj":"Body_part"},{"id":"T28","span":{"begin":493,"end":499},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_2000106"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A27","pred":"uberon_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A28","pred":"uberon_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T140","span":{"begin":111,"end":124},"obj":"Disease"},{"id":"T141","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"T142","span":{"begin":204,"end":245},"obj":"Disease"},{"id":"T143","span":{"begin":204,"end":216},"obj":"Disease"},{"id":"T144","span":{"begin":222,"end":245},"obj":"Disease"},{"id":"T145","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"T146","span":{"begin":302,"end":309},"obj":"Disease"}],"attributes":[{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"},{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0001302"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T335","span":{"begin":13,"end":16},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T336","span":{"begin":97,"end":102},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T337","span":{"begin":97,"end":102},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T338","span":{"begin":97,"end":102},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T339","span":{"begin":97,"end":102},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T340","span":{"begin":111,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T341","span":{"begin":111,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T342","span":{"begin":111,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T343","span":{"begin":111,"end":116},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T344","span":{"begin":310,"end":313},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T345","span":{"begin":460,"end":463},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T346","span":{"begin":544,"end":550},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T357","span":{"begin":531,"end":540},"obj":"Chemical"},{"id":"T358","span":{"begin":554,"end":556},"obj":"Chemical"}],"attributes":[{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_47867"},{"id":"A358","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A359","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T37","span":{"begin":111,"end":124},"obj":"Phenotype"},{"id":"T38","span":{"begin":204,"end":216},"obj":"Phenotype"},{"id":"T39","span":{"begin":222,"end":245},"obj":"Phenotype"},{"id":"T40","span":{"begin":302,"end":309},"obj":"Phenotype"}],"attributes":[{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0001635"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-sentences","denotations":[{"id":"T88","span":{"begin":0,"end":595},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1136","span":{"begin":13,"end":16},"obj":"Gene"},{"id":"1137","span":{"begin":460,"end":463},"obj":"Gene"},{"id":"1138","span":{"begin":554,"end":559},"obj":"Gene"},{"id":"1142","span":{"begin":274,"end":282},"obj":"Species"},{"id":"1143","span":{"begin":396,"end":404},"obj":"Species"},{"id":"1150","span":{"begin":97,"end":109},"obj":"Disease"},{"id":"1151","span":{"begin":111,"end":124},"obj":"Disease"},{"id":"1152","span":{"begin":136,"end":156},"obj":"Disease"},{"id":"1153","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"1154","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"1155","span":{"begin":204,"end":216},"obj":"Disease"},{"id":"1156","span":{"begin":222,"end":245},"obj":"Disease"},{"id":"1157","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"1158","span":{"begin":302,"end":309},"obj":"Disease"},{"id":"1159","span":{"begin":372,"end":381},"obj":"Disease"},{"id":"1160","span":{"begin":410,"end":418},"obj":"Disease"}],"attributes":[{"id":"A1136","pred":"tao:has_database_id","subj":"1136","obj":"Gene:6761"},{"id":"A1137","pred":"tao:has_database_id","subj":"1137","obj":"Gene:6761"},{"id":"A1138","pred":"tao:has_database_id","subj":"1138","obj":"Gene:90865"},{"id":"A1142","pred":"tao:has_database_id","subj":"1142","obj":"Tax:9606"},{"id":"A1143","pred":"tao:has_database_id","subj":"1143","obj":"Tax:9606"},{"id":"A1150","pred":"tao:has_database_id","subj":"1150","obj":"MESH:D006331"},{"id":"A1151","pred":"tao:has_database_id","subj":"1151","obj":"MESH:D006333"},{"id":"A1152","pred":"tao:has_database_id","subj":"1152","obj":"MESH:D002318"},{"id":"A1153","pred":"tao:has_database_id","subj":"1153","obj":"MESH:D003643"},{"id":"A1154","pred":"tao:has_database_id","subj":"1154","obj":"MESH:D003920"},{"id":"A1155","pred":"tao:has_database_id","subj":"1155","obj":"MESH:D006973"},{"id":"A1156","pred":"tao:has_database_id","subj":"1156","obj":"MESH:D002318"},{"id":"A1157","pred":"tao:has_database_id","subj":"1157","obj":"MESH:C000657245"},{"id":"A1158","pred":"tao:has_database_id","subj":"1158","obj":"MESH:D009765"},{"id":"A1159","pred":"tao:has_database_id","subj":"1159","obj":"MESH:D003643"},{"id":"A1160","pred":"tao:has_database_id","subj":"1160","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}

{"project":"2_test","denotations":[{"id":"33073244-29982301-66244616","span":{"begin":182,"end":184},"obj":"29982301"},{"id":"33073244-32380044-66244617","span":{"begin":419,"end":421},"obj":"32380044"}],"text":"High soluble ST2 concentrations also predict worse outcomes and are associated with extension of heart damage, heart failure, increased cardiovascular death, and all-cause mortality.54 Notably, diabetes, hypertension, and cardiovascular diseases are common comorbidities in patients with COVID-19, and obesity has been independently associated with increased severity and mortality among younger patients with COVID-19.66 Circulating concentrations of soluble ST2 correlate with the extent of tissue damage, and might represent an indicator in plasma of IL-33 release and bioactivity in tissues."}